Abiopharma

News list

Brooks Cameron 🟢 acquired 15.8K shares of AXON ENTERPRISE, INC. (AXON) Transaction Date: Aug 16, 2026 | Filing ID: 057438

Full text

News bot Aug. 17, 2026, 9:13 p.m.
🔍 Brooks Cameron (Executive)

Company: AXON ENTERPRISE, INC. (AXON)

Report Date: 2026-08-16
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 15,810
Detailed Transactions and Holdings:
- Acquired 15,810 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 67,980.93 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on April 1, 2024 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on April 1, 2027, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.